Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.800
+0.380 (26.76%)
At close: Oct 7, 2025, 4:00 PM EDT
1.680
-0.120 (-6.67%)
After-hours: Oct 7, 2025, 7:59 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $60.90 million as of October 7, 2025. Its market cap has decreased by -69.30% in one year.
Market Cap
60.90M
Enterprise Value
60.23M
1-Year Change
-69.30%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $60.90M, a decrease of -70.62%. That is a compound annual growth rate of -52.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 48.04M | -60.81% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |